Estados financieros detallados de HeartBeam, Inc. (BEAT): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
Márgenes de los últimos 12 meses: margen bruto 0.0%, margen operativo 0.0%, margen neto 0.0%.
Al precio actual de $0.41, BEAT presenta beneficios negativos (P/E no significativo) y un ROE del -6.87%. La capitalización bursátil es de $23M.
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Ingresos | $208.3M | $286.8M | $399.5M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Coste de Ventas | $78.9M | $114.4M | $149.0M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Bruto | $129.4M | $172.4M | $250.5M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| I+D | $8.4M | $11.1M | $11.2M | $41000 | $133000 | $255000 | $5.7M | $6.8M | $11.1M | $13.4M |
| Generales y Administrativos | $85.2M | $123.9M | $155.3M | $253000 | $655000 | $2.0M | $7.4M | $8.5M | $8.8M | $7.7M |
| Gastos Operativos | $93.6M | $135.0M | $166.5M | $294000 | $788000 | $2.3M | $13.0M | $15.3M | $19.9M | $21.1M |
| Beneficio Operativo | $35.9M | $37.4M | $84.0M | -$294000 | -$788000 | -$2.3M | -$13.0M | -$15.3M | -$19.9M | -$21.1M |
| EBITDA | $30.0M | $24.2M | $92.0M | 0 | 0 | -$2.3M | $69000 | $675000 | -$19.4M | -$21.0M |
| Gastos por Intereses | 0 | $4.9M | $9.4M | $242000 | $280000 | $2.2M | $66000 | 0 | 0 | 0 |
| Beneficio Antes de Impuestos | $15.8M | -$10.4M | $41.5M | -$536000 | -$1.1M | -$4.4M | -$13.0M | -$14.6M | -$19.4M | -$21.0M |
| Impuestos | -$37.7M | $6.7M | -$370000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Neto | $53.4M | -$16.0M | $42.8M | -$536000 | -$1.1M | -$4.4M | -$13.0M | -$14.6M | -$19.4M | -$21.0M |
| BPA | $1.91 | $-0.53 | $1.20 | $-0.10 | $-0.14 | $-0.56 | $-1.59 | $-0.72 | $-0.73 | $-0.62 |
| BPA Diluido | $1.75 | $-0.53 | $1.20 | $-0.10 | $-0.14 | $-0.56 | $-1.59 | $-0.72 | $-0.73 | $-0.62 |
| Acciones en Circulación (Diluidas) | $30.5M | $30.4M | $35.8M | $8.2M | $8.2M | $7.8M | $8.2M | $20.3M | $26.6M | $33.7M |
Cuenta de Resultados (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Ingresos | 0 | 0 | 0 | 0 |
| Beneficio Bruto | 0 | 0 | -$24000 | 0 |
| Beneficio Operativo | -$5.3M | -$5.3M | -$4.7M | -$5.1M |
| EBITDA | -$5.2M | -$5.3M | -$4.7M | -$5.1M |
| Beneficio Neto | -$5.3M | -$5.3M | -$4.7M | -$5.0M |
| BPA | $-0.15 | $-0.15 | $-0.12 | $-0.10 |
| BPA Diluido | $-0.15 | $-0.15 | $-0.12 | $-0.10 |
Balance (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Caja y Equivalentes | $23.1M | $36.0M | $80.9M | $5000 | $24000 | $13.2M | $3.6M | $16.2M | $2.4M | $4.4M |
| Inversiones a Corto | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cuentas por Cobrar | $26.9M | $38.5M | $52.6M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventario | $5.2M | $5.3M | $7.3M | 0 | 0 | 0 | 0 | 0 | 0 | $103000 |
| Activos Corrientes | $59.6M | $90.1M | $146.7M | $7000 | $51000 | $14.0M | $4.0M | $16.8M | $2.8M | $4.7M |
| Inmovilizado Material | $25.8M | $49.2M | $48.4M | $56.4M | 0 | 0 | 0 | $256000 | $450000 | $1.1M |
| Fondo de Comercio | $41.1M | $223.1M | $238.8M | $301.3M | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | $33.5M | $141.7M | $129.7M | $129.6M | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Totales | $199.0M | $524.6M | $586.8M | $7000 | $51000 | $14.0M | $4.0M | $17.1M | $3.3M | $5.8M |
| Cuentas por Pagar | $12.4M | $13.2M | $18.2M | $24.2M | $474000 | $587000 | $1.7M | $556000 | $531000 | $1.1M |
| Deuda a Corto | $1.2M | $2.0M | $5.1M | $42000 | $4.3M | 0 | 0 | 0 | 0 | 0 |
| Pasivos Corrientes | $31.5M | $51.0M | $49.6M | $354000 | $4.8M | $588000 | $1.7M | $1.2M | $1.6M | $3.2M |
| Deuda a Largo | $23.9M | $197.3M | $193.4M | $3.4M | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Totales | $60.1M | $274.9M | $276.3M | $3.7M | $4.8M | $588000 | $1.7M | $1.2M | $1.6M | $3.2M |
| Reservas | -$142.7M | -$158.7M | -$115.9M | -$3.7M | -$4.8M | -$9.2M | -$22.2M | -$36.8M | -$56.3M | -$77.3M |
| Patrimonio Neto | $138.9M | $250.8M | $310.5M | -$3.7M | -$4.8M | $13.4M | $2.4M | $15.9M | $1.7M | $2.6M |
| Deuda Total | $25.2M | $199.4M | $198.5M | $3.4M | $4.3M | 0 | 0 | 0 | 0 | 0 |
| Deuda Neta | $2.1M | $163.3M | $117.7M | $3.4M | $4.3M | -$13.2M | -$3.6M | -$16.2M | -$2.4M | -$4.4M |
| Capital Circulante | $28.1M | $39.2M | $97.0M | -$347000 | -$4.8M | $13.4M | $2.4M | $15.6M | $1.1M | $1.4M |
Balance (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Caja y Equivalentes | $1.9M | $4.4M | $2.0M | $8.7M |
| Activos Totales | $2.9M | $5.8M | $3.9M | $10.6M |
| Pasivos Totales | $2.5M | $3.2M | $3.3M | $2.5M |
| Patrimonio Neto | $406000 | $2.6M | $635000 | $8.2M |
| Deuda Total | 0 | 0 | 0 | 0 |
Flujo de Caja (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Beneficio Neto | $53.4M | -$16.0M | $42.8M | -$536000 | -$1.1M | -$4.4M | -$13.0M | -$14.6M | -$19.4M | -$21.0M |
| Amortizaciones | $14.3M | $28.6M | $40.2M | 0 | 0 | 0 | 0 | 0 | $7000 | $40000 |
| Compensación en Acciones | $6.5M | $7.7M | 0 | 0 | $10000 | $192000 | $1.1M | $3.2M | $4.3M | $5.1M |
| Cambio en Capital Circulante | $4.9M | $11.1M | $57.9M | $76000 | $182000 | -$1.1M | $1.9M | -$662000 | $671000 | $1.6M |
| Flujo de Caja Operativo | $38.9M | $23.8M | $72.7M | -$218000 | -$600000 | -$3.2M | -$9.9M | -$12.1M | -$14.5M | -$14.0M |
| Inversiones (CapEx) | -$10.9M | -$13.7M | -$24.6M | 0 | 0 | 0 | 0 | -$256000 | -$201000 | -$600000 |
| Adquisiciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Recompra de Acciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividendos Pagados | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | $28.0M | $10.1M | $48.1M | -$218000 | -$600000 | -$3.2M | -$9.9M | -$12.3M | -$14.7M | -$14.6M |
Flujo de Caja (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Flujo de Caja Operativo | -$3.2M | -$2.9M | -$3.6M | -$3.3M |
| Inversiones (CapEx) | -$82000 | -$416000 | -$246000 | -$249000 |
| Flujo de Caja Libre | -$3.2M | -$3.3M | -$3.9M | -$3.6M |
| Dividendos Pagados | 0 | 0 | 0 | 0 |
| Compensación en Acciones | $1.4M | $1.4M | $1.2M | $1.7M |
Crecimiento y Márgenes (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Crecimiento Ingresos (anual) | | +37.7% | +39.3% | -100.0% | | | | | | |
| Crecimiento Beneficio Neto (anual) | | -129.9% | +368.4% | -101.3% | -99.3% | -314.6% | -192.7% | -12.9% | -32.9% | -8.1% |
| Crecimiento BPA (anual) | | -127.7% | +326.4% | -107.9% | -46.9% | -300.0% | -183.9% | +54.7% | -1.4% | +15.1% |
| Cambio en Acciones (anual) | | -0.3% | +17.8% | -77.2% | +0.0% | -4.4% | +4.6% | +148.9% | +31.0% | +26.5% |
| Crecimiento FCF (anual) | | -63.9% | +377.0% | -100.5% | -175.2% | -438.3% | -208.0% | -24.1% | -18.8% | +0.6% |
| Margen Bruto | 62.1% | 60.1% | 62.7% | | | | | | | |
| Margen Operativo | 17.2% | 13.0% | 21.0% | | | | | | | |
| Margen EBITDA | 14.4% | 8.5% | 23.0% | | | | | | | |
| Margen Neto | 25.6% | -5.6% | 10.7% | | | | | | | |
| Margen FCF | 13.4% | 3.5% | 12.0% | | | | | | | |
| Tasa Impositiva Efectiva | -238.9% | -64.9% | -0.9% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% |
Datos por Acción (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| FCF por Acción | $0.92 | $0.33 | $1.34 | $-0.03 | $-0.07 | $-0.41 | $-1.22 | $-0.61 | $-0.55 | $-0.43 |
| Dividendo por Acción | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $27.9M | $30.4M | $35.8M | $8.2M | $8.2M | $7.8M | $8.2M | $20.3M | $26.6M | $33.7M |
Qué mirar en Salud / Farma
El pipeline de I+D es el activo invisible. Patentes que caducan = ingresos que evaporan. Mira innovación y flujo de caja.
- I+D / Ingresos — Indica inversión en pipeline futuro. Farma seria reinvierte 15-20%
- Crecimiento EPS 5y — Tras caducidad de patentes, ¿siguen creciendo?
- Margen bruto — Farma de marca >70%. Genéricos mucho más bajo — define el tipo de negocio
- FCF / Net Income — Calidad del beneficio — farma grande debería convertir >90%
- ROIC — Capital reinvertido con eficiencia — clave en farma por ciclos de I+D largos
- Deuda neta / EBITDA — Adquisiciones de farma generan mucha deuda — ojo al post-M&A
- P/E vs historial 10y propio — La mejor comparación es con su propia historia, no con competidores
Rentabilidad
| Rentabilidad sobre capital | -686.78% |
| Rentabilidad sobre capital invertido | -249.58% |
| Rentabilidad sobre activos | -190.81% |
| Margen bruto | 0.00% |
| Margen operativo | 0.00% |
| Margen neto | 0.00% |
Salud financiera
| Deuda / Patrimonio | 0.00 |
| Ratio corriente | 3.66 |
| Piotroski F-Score | 2 |
| Altman Z-Score | -15.18 |
Ratios Clave (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| P/E | 2.46 | -8.85 | 3.91 | -49.21 | -33.50 | -5.50 | -3.07 | -3.26 | -3.15 | -3.87 |
| P/VC | 0.94 | 0.57 | 0.54 | -10.28 | -8.01 | 1.79 | 16.79 | 3.00 | 37.05 | 31.08 |
| P/V | 0.63 | 0.50 | 0.42 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Margen Bruto | 62.1% | 60.1% | 62.7% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Margen Operativo | 17.2% | 13.0% | 21.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Margen Neto | 25.6% | -5.6% | 10.7% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |